Sections
Excerpt
A chemically diverse group of agents are classified as sedative-hypnotics, linked by the ability to induce calm, sedation, sleep, respiratory depression, and coma. (For a detailed review of the pharmacology, see Ciraulo 2014.) Many of the drugs share the property of exerting their pharmacological effects at the gamma-aminobutyric acid (GABA) receptor, but recent research has revealed that these actions at the receptor differ among the agents. Furthermore, emphasis on GABA proved overly simplistic, ignoring both the variety of receptor subtypes and other neurotransmitter systems that have a profound influence on clinical activity and addiction potential. Therefore, in this chapter I address each class of agents individually, emphasizing shared properties and unique characteristics that often explain clinical differences in action. The discussion that follows is limited to agents that act at the GABAA receptor, including benzodiazepines, the Z drug hypnotics, and barbiturates.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).